# R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma

> **NCT00135499** · PHASE3 · TERMINATED · sponsor: **Lymphoma Study Association** · enrollment: 138 (actual)

## Conditions studied

- Lymphoma, Large-Cell, Diffuse

## Interventions

- **DRUG:** Rituximab
- **DRUG:** Doxorubicin
- **DRUG:** Cyclophosphamide
- **DRUG:** Vindesine
- **DRUG:** Bleomycin
- **DRUG:** Prednisone
- **DRUG:** Prednisone
- **DRUG:** Doxorubicin
- **DRUG:** Cyclophosphamide
- **DRUG:** Vincristine

## Key facts

- **NCT ID:** NCT00135499
- **Lead sponsor:** Lymphoma Study Association
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-10-16
- **Primary completion:** 2010-04-27
- **Final completion:** 2010-04-27
- **Target enrollment:** 138 (ACTUAL)
- **Why stopped:** Recruitment too low
- **Last updated:** 2018-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00135499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00135499, "R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00135499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*